

24 Participants who were consented, randomised, set a quit date on Quit.ie or made an appointment for an AC seminar were included in the ITT analysis. With 80% power and two-sided significance level of 5%, a sample size of 139 for each group would be needed to detect superiority between AC and Quit.ie.Īn ‘intention-to-treat’ (ITT) approach, where only CO-validated quitting, as per Russell standard is accepted as valid was used to determine the numerator in both conditions and data from all 300 randomised smokers (149 Quit.ie and 151 Allen Carr) were included in the denominators for the analysis. The quit rates at 3 months were predicted as 25% for AC and 12% for Quit.ie. All registered clients are sent an email from Quit.ie at 3 months requesting confirmation of quit status. An appointment for follow-up was arranged at the TFRI research centre at months 1, 3, 6 and 12 following their target quit date.

Participants were registered on Quit.ie during their first TFRI visit, and an agreed quit date was set. The decision to use medication rested with the client, who was also responsible for arranging the purchase or prescription of any NRT or other medication that they used. As part of the Quit.ie quit plan, participants set their quit date, requested daily support texts and or emails for 1 month and at least two further follow-up communications and arranged to have a counselling phone call from the quit team specialist. They give smokers information and behavioural support on the phone, by text and online through their website and Facebook community. 18 Quit.ie has a team of accredited National Centre for Smoking Cessation and Training (NCSCT, UK) Tobacco Cessation Practitioners.
#ALLEN CARR EASY WAY TO FULL MOVIE FREE#
Quit.ie is an online portal for HSE smoking cessation services, and it is delivered free of charge. Irish and UK white nationals made up 90% of the sample, nine other nationalities were represented and there was equal ethnic distribution for both conditions. Appointments were sent to 551 yielding 300 who met the criteria, and were randomised 251 did not attend as requested and 70 were not contacted once recruitment was completed in February 2016. The remaining 2035 were contacted by email on a first-come-first-served basis 1414 did not respond and 631 responded positively. A total of 3065 smokers responded, 112 did not leave contact details, 918 were excluded on exclusion criteria. Exclusion criteria were doctor-diagnosed, acute cardiac or respiratory illness or serious psychiatric illness and must not be currently undergoing treatment for alcohol or illicit drug use.

The inclusion criteria were that participants be 18 years or older, smoking a minimum of 5 cigarettes per day, have a good knowledge of the English language, as AC was delivered in English, and agree to attend all five study visits in TFRI, Dublin.
#ALLEN CARR EASY WAY TO FULL MOVIE TRIAL#
In this study, we compare Allen Carr’s Easyway to Stop Smoking (AC) with the National Online Smoking Cessation Service, Quit.ie, in a randomised clinical trial (RCT). 20 AC does not include pharmacotherapy, and the behavioural intervention does not seem to be based on the transtheoretical model of behaviour change. 20–22 The scientific basis of the method is also unclear. 19 There has been very little empirical research on the efficacy of the AC method.

The method claims to have helped more than 30 million smokers quit, with a 90% quit rate advertised on its website. The Allen Carr method has been used for over 30 years and is available in 150 centres in over 50 different countries. Recently, efforts have been made to improve the reach and impact of smoking cessation services in Ireland including the implementation of mobile phone, internet and social media-based interventions. 1–10 The success rates achieved are variable but are of the order of 7%–31% quit at 12 months. Established, effective and cost-effective treatments for tobacco dependence include brief intervention, psychological support and pharmacotherapy, including nicotine replacement therapy (NRT), varenicline and bupropion, which have a high level of proven success in previous scientific studies.
